Miransertib (ARQ 092) HCl
10mM in DMSO
Reagent
Code: #204194
CAS Number
1313883-00-9
blur_circular Chemical Specifications
scatter_plot
Molecular Information
Weight
468.98 g/mol
Formula
C₂₇H₂₅ClN₆
inventory_2
Storage & Handling
Storage
-20°C
description Product Description
Used in research for treating overgrowth syndromes and cancers driven by PI3K/AKT pathway mutations. Shows potential in PROS (PIK3CA-Related Overgrowth Spectrum) by reducing abnormal tissue growth. Investigated for Proteus syndrome and other conditions with AKT activation. Inhibits AKT signaling, which helps control cell growth and survival. Currently in clinical trials, not approved for general use. Also studied in combination with other targeted therapies to enhance anti-tumor effects.
shopping_cart Available Sizes & Pricing
Miransertib (ARQ 092) HCl
Used in research for treating overgrowth syndromes and cancers driven by PI3K/AKT pathway mutations. Shows potential in PROS (PIK3CA-Related Overgrowth Spectrum) by reducing abnormal tissue growth. Investigated for Proteus syndrome and other conditions with AKT activation. Inhibits AKT signaling, which helps control cell growth and survival. Currently in clinical trials, not approved for general use. Also studied in combination with other targeted therapies to enhance anti-tumor effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
Total
฿0.00
THB